Danny Landau
University of Florida Health
4 Papers
11 Citations
Danny Landau is an academic researcher from University of Florida Health. The author has contributed to research in topics: CD8 & Common hepatic artery. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Phase I/II clinical trial of ALT-801, a T-cell receptor/IL-2 fusion protein, plus gemcitabine and cisplatin in urothelial cancer.
Mayer Fishman,Julio Hadjenberg,Timothy M. Kuzel,Amit Mahipal,Charles J. Rosser,Danny Landau,Shilpa Gupta,Daniel A. Vaena,Sanjiv S. Agarwala,John Francis Mahoney,Jean H. Hoffman-Censits,Wayne Harris,Mohammed M. Milhem,Jeffrey S. Weber,Peter R. Rhode,Tessa Schutt,Liza Hernandez,Bee-Yau Huang,Hing C. Wong +18 more
TL;DR: ALT-801 is a novel and potentially active immunotherapy for urothelial cancer and more patients are in treatment on the open phase 2 expansion portion of the study (NCT01326871), and updated interim results are anticipated.
7
Molecular genetic testing patterns for patients with newly diagnosed acute myeloid leukemia (AML) enrolled in the CONNECT MDS/AML disease registry.
Daniel A. Pollyea,Tracy I. George,Kathryn Foucar,Harry P. Erba,Michael A. Thompson,Mehrdad Abedi,Gail J. Roboz,Danny Landau,John M. Pagel,Karen Seiter,Christopher R. Cogle,Melissa Nifenecker,Arlene S. Swern,Pavel Kiselev,Mary M. Sugrue +14 more
TL;DR: Recurrent mutations in AML-associated genes have prognostic value and may help guide treatment decisions, and molecular genetic testing patterns for AML in clinical practice are largely dominated by single nucleotide polymorphism.
3
The Potential Harm of Prostate Cancer Health Supplements
TL;DR: Patients should exercise caution in selecting nonprescription therapies for prostate health and should receive education from their physicians or pharmacists if seeking these products that contain selenium or vitamin E.
1
Is Pancreatic Mass always Adenocarcinoma
TL;DR: A57-year-old man with past medical history of diabetes, hypertension and depression who was evaluated for obstructive jaundice, and was found on CT scan of abdomen to have a hypoenhancing 2.6 x 2.1 cm mass highly suspicious for pancreatic adenocarcinoma.